Other languages Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq Other stock markets 21:00:00 26/04/2024 BST			5-day change	1st Jan Change
64.06 ^USD	+2.23%		+3.12%	-16.98%

04-26	Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	CI
04-23	Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	04-26
Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says	03-28
Année faste en 2023 pour les levées de fonds à l'EPFL	02-12
Bio-Techne Seeks M&A	02-01
Bio-Techne's Fiscal Q2 Adjusted Earnings Fall, Net Sales Rise	02-01
Bio-Techne Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-01
Bio-Techne Corporation Announces to Pay A Dividend for the Quarter Ended December 31, 2023, Payable February 26, 2024	02-01
Bio-Techne Corporation Sets New Standard with the Development of A Next-Generation, Protease-Free RNAscope Spatial Multiomics Workflow	01-29
Bio-Techne Corporation Appoints Kim Kelderman as Chief Executive Officer Effective February 1, 2024	01-05
Bio-Techne Corporation Appoints Matthew F. Mcmanus as President, Diagnostics and Genomics Segment, Effective January 8, 2024	01-05
Bio-Techne Files Drug Master File With US FDA for ExCellerate GMP for Stem Cell Therapy	12-20
Bio-Techne's Fiscal Q1 Adjusted Earnings Decline, Net Sales Rise	31/10/23
Bio-Techne Corporation Reports Earnings Results for the First Quarter Ended September 30, 2023	31/10/23
Bio-Techne Corporation Announces to Pay A Dividend for the Quarter Ended September 30, 2023, Will Be Payable November 24, 2023	31/10/23
Refunding relief stokes bond-led bounce	31/10/23
Bio-Techne Corporation to Present New Data Using Lunaphore's Comet Technology at the Society for Immunotherapy of Cancer's 38th Annual Meeting	25/10/23
Bio-Techne Corporation Announces Executive Changes	19/10/23
Bio-Techne Corporation Announces Chief Executive Officer Changes	19/10/23
Bio-Techne Launches Maurice Chromeleon Driver Kit for Maurice Instrument Control	26/09/23
Bio-Techne Corporation Launches the New Maurice Chromeleon Driver Kit, Which Enables Control of its Maurice? Instrument with the Thermo Scientific? Chromeleon? Chromatography Data System	26/09/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Bio-Techne Corporation

Equities

TECH

US09073M1045

Other languages

Filters